CA2326002A1 - Chlamydia proteins and their uses - Google Patents

Chlamydia proteins and their uses Download PDF

Info

Publication number
CA2326002A1
CA2326002A1 CA002326002A CA2326002A CA2326002A1 CA 2326002 A1 CA2326002 A1 CA 2326002A1 CA 002326002 A CA002326002 A CA 002326002A CA 2326002 A CA2326002 A CA 2326002A CA 2326002 A1 CA2326002 A1 CA 2326002A1
Authority
CA
Canada
Prior art keywords
seq
leu
chlamydia
infection
ser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002326002A
Other languages
English (en)
French (fr)
Inventor
Daniel D. Rockey
John P. Bannantine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oregon State Board of Higher Education
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2326002A1 publication Critical patent/CA2326002A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/295Assays involving biological materials from specific organisms or of a specific nature from bacteria from Chlamydiales (o)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002326002A 1998-04-20 1999-04-20 Chlamydia proteins and their uses Abandoned CA2326002A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US8243898P 1998-04-20 1998-04-20
US60/082,438 1998-04-20
US8258898P 1998-04-21 1998-04-21
US60/082,588 1998-04-21
US8645098P 1998-05-22 1998-05-22
US60/086,450 1998-05-22
PCT/US1999/008744 WO1999053948A1 (en) 1998-04-20 1999-04-20 Chlamydia proteins and their uses

Publications (1)

Publication Number Publication Date
CA2326002A1 true CA2326002A1 (en) 1999-10-28

Family

ID=27374277

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002326002A Abandoned CA2326002A1 (en) 1998-04-20 1999-04-20 Chlamydia proteins and their uses

Country Status (4)

Country Link
EP (1) EP1073458A4 (de)
AU (1) AU754122B2 (de)
CA (1) CA2326002A1 (de)
WO (1) WO1999053948A1 (de)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7374059B2 (en) 2001-10-05 2008-05-20 Industrial And Environmental Concepts, Inc. Covering systems and venting methods
US9591797B2 (en) 2013-11-14 2017-03-14 Industrial & Environmental Concepts, Inc. Cover systems with fusion welds
US11141952B2 (en) 2015-04-06 2021-10-12 Industrial & Environmental Concepts, Inc. Sludge covers, sludge management systems, and related methods

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9828000D0 (en) 1998-12-18 1999-02-10 Chiron Spa Antigens
US7811592B2 (en) 2000-08-16 2010-10-12 Auburn University Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of Chlamydia
WO2002047718A2 (en) * 2000-12-15 2002-06-20 Board Of Regents, The University Of Texas System Methods and compositions for vaccination comprising nucleic acid ad/or polypeptide sequences of $i(chlamydia)
US20030185848A1 (en) * 2000-12-15 2003-10-02 Board Of Regents, The University Of Texas System Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of Chlamydia psittaci
US20070149474A1 (en) 2000-12-15 2007-06-28 Auburn University Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of chlamydia
US8206724B2 (en) 2000-12-15 2012-06-26 Auburn University Method and compositions for vaccination comprising nucleic acid and/or polypeptide sequence of chlamydia
WO2003068988A1 (en) * 2002-02-11 2003-08-21 Secretary, Department Of Atomic Energy A method of pcr based detection and identification of rice blast fungus magnaporthe grisea

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100735651B1 (ko) * 1997-11-28 2007-07-06 세로노 제네틱스 인스티튜트 에스.에이. 클라미디아 트라코마티스 게놈 서열과 폴리펩티드, 이의단편 및 이의 용도, 특히, 감염의 진단, 예방 및 치료 용도
JP2002531129A (ja) * 1998-12-08 2002-09-24 コリクサ コーポレイション クラミジア感染の処置および診断のための化合物および方法

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7374059B2 (en) 2001-10-05 2008-05-20 Industrial And Environmental Concepts, Inc. Covering systems and venting methods
US9591797B2 (en) 2013-11-14 2017-03-14 Industrial & Environmental Concepts, Inc. Cover systems with fusion welds
US11141952B2 (en) 2015-04-06 2021-10-12 Industrial & Environmental Concepts, Inc. Sludge covers, sludge management systems, and related methods

Also Published As

Publication number Publication date
EP1073458A4 (de) 2005-01-12
EP1073458A1 (de) 2001-02-07
WO1999053948A1 (en) 1999-10-28
AU754122B2 (en) 2002-11-07
AU3659099A (en) 1999-11-08

Similar Documents

Publication Publication Date Title
CA2373021A1 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
EP0756630B1 (de) Rekombinant pgp3, verfahren zu dessen herstellung, und dessen verwendung in der diagnose und therapie
US7244613B2 (en) Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
JP2003510050A (ja) クラミジア抗原および対応するdna断片ならびにその使用
JP3440221B2 (ja) アクチノバチルス・プレウロニウモニアからのタンパク質
CA2408199A1 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO1995028487A9 (en) Recombinant pgp3, methods of preparation and use in diagnosis and therapy
CA2294651A1 (en) Surface exposed proteins from chlamydia pneumoniae
CA2326002A1 (en) Chlamydia proteins and their uses
EP2447278B1 (de) Neue immunogene Proteine von Leptospira
CA2190359C (en) Nucleic acids of rochalimaea henselae and rochalimaea quintana and methods and compositions for diagnosing rochalimaea henselae and rochalimaea quintana infection
CA2516971A1 (en) Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof
MXPA01009256A (es) Antigenos de chlamydia y fragmentos de acido desoxirribonucleico correspondientes y usos de los mismos.
US6746676B1 (en) Chlamydia proteins and their uses
US6406887B1 (en) Compositions for diagnosing Rochalimaea henselae and Rochalmaea quintana infection
EP2363407A1 (de) Neuartige Brachyspira-Sequenzen, immunogene Zusammensetzungen, Herstellungsverfahren dafür und Verwendung davon
EP1057035A2 (de) Verfahren zur auffindung von intimin produzierender mikroorganismen
EP1140998B1 (de) Chlamydia antigene, entsprechende dna fragmente und ihre verwendungen
EP0915977A1 (de) In vivo exprimierte polypeptide von b. burgdorferi
JP2003512017A (ja) クラミジア抗原および対応するdna断片ならびにその使用
CA2352759A1 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2000062069A1 (en) Method of detecting intimin-expressing microorganisms
CA2296869A1 (en) A surface-exposed lipoprotein to campylobacter jejuni involved in adherence to hep-2 cells
MXPA99009688A (en) New proteins of antinobacillus pleuropneumon
MXPA01006576A (en) Chlamydia

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued